First-ever treatments for GA offer hope in the battle against this relentlessly progressive retinal disease. In this roundtable-style educational activity, expert retina specialists will review best practices in GA diagnosis and deliberate new conundrums that have arisen about whether, when, and how to initiate GA treatment in eligible patients given the recent availability of new agents.
- Provider:Paradigm Medical Communications, LLC
- Activity Link: https://ce.paradigmmc.com/a/HKTBAC
- Start Date: 2024-03-28 05:00:00
- End Date: 2024-03-28 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
- Commercial Support: Source: Heidelberg Engineering, Inc. - Amount: 500.0 - Is Kind Support: False Source: Iveric Bio, Inc. - Amount: 152175.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Competence, Learner Knowledge, Learner Performance
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest